Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine HCl in presbyopia
NCT06451666Phase 3Not yet recruiting
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by CSPC Ouyi Pharmaceutical. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT06451666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06451666.